Securities code: Shanghai Shen Lian Biomedical Corporation(688098) securities abbreviation: Shanghai Shen Lian Biomedical Corporation(688098) Announcement No.: 2022014 Shanghai Shen Lian Biomedical Corporation(688098) Pharmaceutical (Shanghai) Co., Ltd
Announcement on holding 2021 annual performance presentation meeting
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
Important content tips:
Meeting time: 15:00-16:00 p.m. on Friday, May 13, 2022 Venue: Shanghai Stock Exchange roadshow Center (website: http://roadshow.sseinfo.com./ ）Meeting mode: online interaction of Shanghai Securities roadshow Center
Investors can log in to the homepage of the website of Shanghai Securities roadshow center before 16:00 on May 6 (Friday) to May 12 (Thursday), 2022, click on the column of “pre collection of questions” or through the company’s email [email protected]. Ask questions. The company will answer the questions generally concerned by investors at the briefing.
Shanghai Shen Lian Biomedical Corporation(688098) Pharmaceutical (Shanghai) Co., Ltd. (hereinafter referred to as “the company”) has released the company’s annual report for 2021 on April 28, 2022. In order to facilitate investors to have a more comprehensive and in-depth understanding of the company’s operating results and financial situation in 2021, the company plans to hold a 2021 annual performance presentation meeting from 15:00 to 16:00 on May 13, 2022 to exchange issues of concern to investors.
1、 Description meeting type
The investor briefing will be held in the form of online interaction. The company will conduct interactive communication and communication with investors according to the specific conditions of operating results and financial indicators in 2021, and answer the questions generally concerned by investors within the scope of information disclosure.
2、 Explain the time and place of the meeting
(I) meeting time: 15:00-16:00 PM, May 13, 2022
(II) venue of the meeting: Shanghai Stock Exchange Shanghai Securities roadshow Center (website: http://roadshow.sseinfo.com./ ）
(III) meeting mode: online interaction of Shanghai Securities roadshow Center
3、 Participants
Director and general manager: Ms. Gao Yanchun
Independent director: Mr. Tong Guangzhi
Director, deputy general manager and Secretary of the board of directors: Mr. Nie Wenhao
Chief financial officer: Ms. Li Ruiling
4、 Investor participation mode
(I) investors can log in to the Shanghai Securities roadshow center through the Internet from 15:00 to 16:00 p.m. on Friday, May 13, 2022（ http://roadshow.sseinfo.com./ ）, participate in this performance presentation online, and the company will answer the questions of investors in time.
(II) investors can log in to the homepage of the website of Shanghai Securities roadshow center from Friday, May 6, 2022 to Thursday, May 12, 2022 before 16:00, and click the column of “pre collection of questions”（ http://roadshow.sseinfo.com./questionCollection.do ）, according to the activity time, select this activity or through the company email [email protected]. Ask questions to the company, and the company will answer questions generally concerned by investors at the briefing.
5、 Contact person and consultation method
Contact: Office of the board of directors
Email: [email protected].
6、 Other matters
After the investor briefing meeting is held, investors can go through the Shanghai Securities roadshow center（ http://roadshow.sseinfo.com./ ）Check the convening and main contents of this investor briefing.
It is hereby announced.
Board of directors of Shanghai Shen Lian Biomedical Corporation(688098) Pharmaceutical (Shanghai) Co., Ltd. May 5, 2022
